Company intelligence / Profile preview

Flow Medical

Chicago, Illinois, United Statesbutterfly-medical.com ↗

Ownership: Private
Development stage: Other

Overview

Flow Medical is developing a novel, minimally invasive thrombolysis catheter designed to personalize and improve the treatment of acute pulmonary embolism. The company has raised significant seed funding and is preparing for first-in-human studies. Its device aims to optimize clot dissolution while minimizing complications such as bleeding or long-term pulmonary hypertension by enabling more precise control over therapy delivery.[3][4][5] No clinical results have been published yet.

Therapeutic areas: Cardiovascular
Modalities: DeviceThrombolysis Catheter
Industry: Therapeutic Medical Devices

Partnerships

University of Chicago Medical Center/UCM Ventures (strategic investor and academic partner)[4]

Beyond the preview

Go deeper on Flow Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flow Medical.

Explore the full profile